GlaxoSmithKline licenses production of generic AIDS drugs in South AfricaBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7317.828/b (Published 13 October 2001) Cite this as: BMJ 2001;323:828
- Susan Mayor
The pharmaceutical company GlaxoSmithKline has granted a voluntary licence to a company in South Africa to manufacture and distribute low cost generic versions of three of its AIDS drugs, on the basis of an agreement announced last week.
The agreement allows the pharmaceutical company Aspen Pharmacare, the biggest manufacturer of generic drugs in South Africa, to manufacture three AIDS drugs—zidovudine (Retrovir), lamivudine (Epivir), and a combination of zidovudine and lamivudine (Combivir).
These drugs are currently the …